Non-alcoholic fatty liver disease
Peer reviewed by Dr Colin Tidy, MRCGPLast updated by Dr Doug McKechnie, MRCGPLast updated 22 Feb 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
In this series:Liver disease and alcoholAlcohol and sensible drinking - safe limits of alcoholAlcoholism and problem drinkingAlcohol withdrawal and alcohol detoxification
Non-alcoholic fatty liver disease (NAFLD) describes a range of conditions caused by a build-up of fat within liver cells.
In this article:
It is very common and in many cases is linked to being obese or overweight. Most people with NAFLD do not develop serious liver problems. In some people, the build-up of fat in the liver can lead to serious liver disease. However, all people with NAFLD have an increased risk of developing cardiovascular problems such as heart attacks and stroke.
If you are obese or overweight, the main treatment advised for NAFLD is usually gradual weight loss and regular exercise. This not only helps with NAFLD, but will help reduce your risk of developing cardiovascular problems. Other treatment methods are discussed below.
Continue reading below
What is non-alcoholic fatty liver disease?
NAFLD describes a range of conditions caused by a build-up of fat within liver cells. NAFLD occurs in people who do not drink excessive amounts of alcohol, and so alcohol is not the cause. People who drink excessive amounts of alcohol can develop a condition called 'alcoholic fatty liver disease'.
Most people with NAFLD only have the early stage - 'simple fatty liver'. Only a minority will progress to develop inflammation of the liver (called non-alcoholic steatohepatitis, or NASH). And, only a minority of people with NASH will progress to develop cirrhosis. It is not clear why some people with simple fatty liver progress to the more severe forms of NAFLD, and most do not.
It is helpful to divide NAFLD into four stages:
Simple fatty liver (hepatic steatosis)
Normally, very little fat is stored in liver cells. Simple fatty liver means that excess fat builds up (accumulates) in liver cells. For most people, simple fatty liver does not cause any harm or problems to the liver, although it might be picked up on blood tests done for another reason - this is usually how it's detected. However, in some people it can progress to more severe forms of NAFLD.
Non-alcoholic steatohepatitis (NASH)
n this condition the excess fat in the liver cells is associated with, or may cause, inflammation of the liver. ('Steato' means fat, and 'hepatitis' means inflammation of the liver). This is much less common than simple fatty liver.
Fibrosis
Any form of persistent hepatitis, including steatohepatitis, may eventually cause scar tissue (fibrosis) to form within the liver. When fibrosis first develops often there are many liver cells that continue to function quite well.
Cirrhosis
This is a serious condition where normal liver tissue is replaced by a lot of fibrosis (scarring). The structure and function of the liver are badly disrupted. It is, in effect, like a severe form of liver fibrosis. Many liver conditions can lead to cirrhosis, including NAFLD. Severe cirrhosis can lead to liver failure. See the separate leaflet called Cirrhosis for more details.
Other forms of fatty liver
A condition similar to NAFLD can affect people who do drink a lot of alcohol. Read more about alcohol and liver disease for more details. Another fatty liver condition called fatty liver of pregnancy is a rare but serious condition of pregnancy. In this condition a lot of fat builds up in the liver cells and causes damage quite quickly. The cause is not known. Symptoms include being sick (vomiting), tummy (abdominal) pain and jaundice. Jaundice is a condition caused by a build-up in the body of a chemical called bilirubin, where your skin and other body parts turn a yellow colour.
The rest of this section is only about NAFLD.
Continue reading below
What does the liver do?
The liver is in the upper right part of the tummy (abdomen). Its functions include:
Storing fuel for the body. Much of the food we eat is broken down by the body into a type of sugar called glucose. This is what our bodies use for energy. Glucose can't be stored so it is turned into a storage version called glycogen. This is kept in the liver and, when we need energy, it releases it in the form of glucose. The liver also stores iron and vitamins.
Making proteins that are essential for blood to clot (clotting factors).
Helping to remove or process alcohol, medicines and poisons from the body.
Making a type of fat called cholesterol. This is needed in the body, although too much of it causes harm.
Making a juice called bile, which digests fat. This passes from the liver to the gut down the bile duct. Bile breaks down the fats in food so that they can be absorbed from the bowel.
How common is non-alcoholic fatty liver disease?
NAFLD is the most common persistent (chronic) liver disorder in western countries such as the UK. It is thought to occur in about 1 in 5 adults in the UK and in up to 4 in 5 adults who are obese. (However, most of these people have 'simple fatty liver' and not the more serious types of NAFLD.)
People with NAFLD have a higher chance of developing type 2 diabetes and cardiovascular disease (this includes heart attacks and strokes). Also, as NAFLD is common, some people with NAFLD also have another liver disorder. NAFLD can make the other liver disorder worse.
The risk factors for developing NAFLD include:
Obesity
Most people with NAFLD are obese or overweight. However, the relationship between body fat and NAFLD, and factors that determine which people with obesity will develop NAFLD, are not clear. So, for example, some people who are only mildly overweight develop NAFLD. On the other hand, some people who are very obese do not develop NAFLD.
Diabetes
People with type 2 diabetes have an increased risk of developing NAFLD. However, there is no increased risk for those with type 1 diabetes.
Age
NAFLD is more common in people aged over 50 years. It is also more common in men.
High blood pressure (hypertension)
People with hypertension are at a greater risk of developing NAFLD.
High level of blood fats (hyperlipidaemia)
If you have a high level of cholesterol and/or triglycerides in your blood then you have a higher risk of developing NAFLD.
Very rapid weight loss
For example, NAFLD develops in some people following surgery to reduce obesity. This may be due to rapid changes of fats and fatty acids in the blood that occur when weight loss is rapid.
Medicines
Medication, like methotrexate and tamoxifen for example, can, rarely, cause NAFLD.
Continue reading below
What are the symptoms of non-alcoholic fatty liver disease?
Most people with simple fatty liver or non-alcoholic steatohepatitis (NASH) have no symptoms. However, some people with simple fatty liver or NASH have a nagging persistent pain in the upper right part of the tummy (abdomen), over an enlarged liver. You may feel generally tired if you have NASH. As most people do not have symptoms, the diagnosis is often first suspected when an abnormal blood test result occurs.
A small proportion of people with NAFLD develop cirrhosis. Cirrhosis is a condition where normal liver tissue is replaced by a lot of scar tissue (fibrosis).
How is non-alcoholic fatty liver disease diagnosed?
There is no simple test that can confirm NAFLD. Blood tests called liver function tests (LFTs) measure the blood levels of certain chemicals (enzymes) made by the liver cells. An abnormal pattern of LFTs may suggest that you have NAFLD. However, many other liver conditions can cause abnormal LFTs.
Therefore, if you have abnormal LFTs, a doctor will usually then do various other blood tests to rule out other causes of liver problems. For example, blood tests to detect various infections (such as hepatitis B and hepatitis C) and other causes of liver damage.
LFTs are tests that are done for various reasons. Therefore, NAFLD is often first suspected when an abnormal result occurs when the tests are done for an unrelated reason.
A scan of the liver can be helpful. For example, an ultrasound scan, CT scan or MRI scan. The scan can show an enlarged liver compatible with the diagnosis of NAFLD, and can also show signs of other causes of liver problems. However, a scan cannot definitely diagnose NAFLD.
The diagnosis of NAFLD is usually based on the abnormal LFTs and scan being compatible with NAFLD, and ruling out other causes of liver problems. If there is doubt about the diagnosis, a specialist may arrange a small sample (biopsy) to be taken from your liver.
This can be looked at under the microscope and can show the extent of any fatty accumulation, inflammation, scarring, etc, in the liver. See the separate leaflet called Liver Biopsy for more details.
However, a liver biopsy is not routinely done when simple fatty liver or non-alcoholic steatohepatitis (NASH) is the likely diagnosis, as there is some risk involved when doing a liver biopsy. A liver biopsy is mainly done if the diagnosis is in doubt, or if there is concern that cirrhosis has developed.
Blood tests can look for signs of fibrosis (scarring) of the liver. GPs might use a calculator called FIB-4 to estimate how likely there is to be liver scarring. Another blood test, called the Enhanced Liver Fibrosis (ELF®) test, can be useful as well for this.
A test called a FibroScan® is increasingly being used for people with NAFLD. A FibroScan® checks the stiffness of the liver. It can be used to detect liver scarring, including signs of cirrhosis. In some cases, it can avoid the need for a liver biopsy. Currently, in the UK, it's mainly used by hospital specialists for people who are at high risk of having liver scarring, although it might be used more widely in future.
What is the treatment for non-alcoholic fatty liver disease?
Weight reduction
Most cases of NAFLD are linked to being obese or overweight. There is good evidence that a programme of gradual weight loss and regular exercise can reduce the amount of fat in your liver. So, if you have simple fatty liver or mild NASH, this may prevent or delay the progression of NAFLD. It may reduce your chance of developing cirrhosis - a condition where normal liver tissue is replaced by a lot of scar tissue (fibrosis).
Aerobic exercise and diet changes are the most effective way to manage NAFLD. Try to aim for 150-200 minutes of moderate-intensity exercise a week - split over 3-5 sessions. It's a good idea to drink water instead of sugary drinks. Switching to a Mediterranean diet can reduce liver fat, even if you don't lose weight. See the weight loss leaflet for more ideas.
In some people who are very obese, obesity surgery may be considered, as studies have shown that this may help to improve NASH.
Treatment of linked conditions and risk factors
As mentioned, having NAFLD increases your risk of developing cardiovascular disease. In fact, people with NAFLD are actually more likely to become ill and die from cardiovascular diseases such as heart attacks than from a liver problem. Therefore, your doctor is likely to stress the importance of reducing any 'lifestyle' risk factors that increase the risk of developing cardiovascular disease. For example, not smoking, keeping your weight in check, taking regular exercise and eating a healthy balanced diet. See the separate leaflet called Cardiovascular Disease (Atheroma) for more details. Also, to treat high blood pressure (hypertension) and a high cholesterol level (hyperlipidaemia), if appropriate.
If you have diabetes, good control of your blood sugar (glucose) level is thought to help reduce the risk of NAFLD becoming worse.
It's important not to drink alcohol above the national recommended limits - which is a maximum of 14 units a week, spread across three days or more, ideally with several drink-free days each week. No amount of alcohol is completely risk-free, but it's thought that drinking below these levels is low risk.
Medication that affects the liver itself
Various medicines have been suggested as possible treatments for NAFLD. At the moment, no drugs are specifically licensed to treat NAFLD, and we don't have any medicines that are suitable to treat NAFLD in the early stages (such as simple fatty liver).
For people with a lot of liver scarring due to NAFLD, two medicines seem to help to reduce scarring. These are vitamin E, and pioglitazone. These might be offered by liver specialists.
What is the outlook?
The outlook (prognosis) for most people with NAFLD, is that the condition does not progress beyond simple fatty liver or non-alcoholic steatohepatitis (NASH). Cirrhosis - a condition where normal liver tissue is replaced by a lot of scar tissue (fibrosis) - and serious liver problems do not develop in most cases. The condition may reverse and even go away by weight loss (if you are overweight or obese) or with good control of diabetes (if diabetes is the cause).
However, fatty liver does progress to NASH in some people and NASH progresses to cirrhosis in some people. It is not clear why some people with NASH (and not others) progress to cirrhosis. Cirrhosis is very serious; it can lead to liver failure and may be fatal. A liver transplant may be required in very severe cirrhosis.
It is estimated that, on average:
About 2 in 100 people with simple fatty liver progress to cirrhosis over 15-20 years.
About 12 in 100 people with NASH progress to cirrhosis over about eight years.
So, most people with NAFLD do not develop serious liver disease. However, because NAFLD has become very common in recent years (probably because obesity has become much more common), NAFLD has become a common cause of cirrhosis.
However, also remember that cardiovascular disease is the most common cause of illness and death in people with NAFLD. Perhaps the most important 'take home message' if you are diagnosed with NAFLD is not to focus too much on your liver. Rather, concentrate on reducing any risk factors for developing cardiovascular problems. This is mainly lifestyle changes - in particular, diet, weight loss and exercise for most people and giving up smoking if you smoke.
Further reading and references
- Non-alcoholic fatty liver disease (NAFLD); NICE CKS, October 2021 (UK access only)
- EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
- EASL Policy Statement on Food, obesity and Non-Alcoholic Fatty Liver Disease (NAFLD); European Association for the Study of the Liver, 2019
Article history
The information on this page is written and peer reviewed by qualified clinicians.
Next review due: 6 Jan 2028
22 Feb 2023 | Latest version
Are you protected against flu?
See if you are eligible for a free NHS flu jab today.
Feeling unwell?
Assess your symptoms online for free